Roche rejects MP's eye drug criticism

A Federal MP has accused pharmaceutical manufacturer Roche of pushing a more expensive eye treatment on patients, while “refusing” to recommend a cheaper alternative on the PBS.

Liberal MP Andrew Laming told the House of Representatives the cost of the injectable eye medication Lucentis was significantly greater than Avastin, which was not yet on the PBS but "clinically identical in its outcomes".

Lucentis was the “most expensive drug on Australia’s PBS”, according to Mr Laming, who said the treatment cost $2,000 per injection, and had an overall PBS cost of $309 million

Latest

Trending